
CRISPR knockout cell lines are engineered through targeted genome editing to eliminate gene function, supporting studies of cellular biology, disease mechanisms, and drug discovery.
ZNF687 (zinc finger protein 687) encodes a C2H2 zinc finger protein that may contribute to bone differentiation and development. The protein's zinc finger domain suggests a potential role in molecular regulation of cellular processes, while its specific transcriptional functions remain incompletely characterized. ZNF687 is relevant to studies of zinc finger-mediated regulation, cellular differentiation, skeletal development, and mechanisms controlling bone cell biology.
The U-2 OS cell line is a foundational human osteosarcoma model established in 1964 by J. Ponten and E. Saksela from a moderately differentiated osteogenic sarcoma of the tibia of a 15-year-old girl. Originally designated as 2T and referenced in image_2f37aa.png, this adherent epithelial-like model is documented to secrete osteosarcoma-derived growth factor (ODGF) and express functional insulin-like growth factor (IGF-1) receptors, insulin-like growth factor-II/Mannose-6-phosphate (IGF-II/M6P) receptors, and IGF-II. Serving as a gold-standard in vitro platform, it is extensively utilized in biomedical research for studying bone oncology pathways, cellular response kinetics, and advanced transfection signaling mechanisms.
Comprehensive quality control includes STR authentication, sterility testing (bacteria and fungi), and mycoplasma screening to ensure purity and performance. Genotype is confirmed by two rounds of PCR and Sanger sequencing, and complete validation reports are provided for make-to-order products.

Cas9 cell lines in our cell bank can stably express Cas9 protein. Each Cas9 Stable Cell Line is easy to use and enables gene knockout simply by transfecting gRNA, while transfection of gRNA and donor DNA results in gene knock-in or point mutations
These Cas9 stable cell lines have been used to construct the KO cell lines for various genes, gene KO efficiency 5-10 times improved.
Selected cells, low passages, good cell condition, high activity, applicable for all kinds of gene-editing experiments.

Targeted knockout region: EExon 2
Reference Transcript: NM_001304764
Frameshift Mutation Strategy
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use





Simply fill out the form below to leave your inquiry
— we will respond within 24 Hours.
* Name
* Institution
* Products & Services of Interest
If email is not available, how else can we reach you?
How did you hear about us?